Donate   |   Home   |   Contact Us   |   Sign In   |   Join Now
Deep Learning Advances in MedTech: Unlocking Investment Opportunities
View Registrations Tell a Friend About This EventTell a Friend
Deep Learning Advances in MedTech: Unlocking Investment Opportunities

When: Tuesday, December 10, 2019
6:00 - 8:30 pm
Where: Goodwin Procter
620 8th Ave.
(bet 40-41st Sts.)
New York, New York  10018
United States
Contact: Administrator

Online registration is closed.
« Go to Upcoming Event List  

Deep Learning Advances in MedTech: Unlocking Investment Opportunities

Join us for a panel discussion on the business and investment opportunities that have opened up in the medical devices sector due to breakthroughs in data science (AI and Deep Learning algorithms) and changing regulatory, business, and reimbursement models. The speakers, including leaders in medical devices, reimbursement, data science, and strategy, will address the following:

· The changing landscape of software as medical devices and software in medical devices due to AI

· Opportunities for entrepreneurs and investors in the medical devices sector

· How medical devices are helping in the optimization of the patient's journey and making healthcare delivery more efficient.

· Changing reimbursement models to increase revenue

· How to improve patient engagement and healthcare outcomes via medical devices platform and collaboration with high-tech consumer companies

· Analyzing the role and value of medical devices in therapies of tomorrow

Confirmed Speakers (to date)

Bobby Ghoshal -  CTO, ResMed

Leo Grady 
- CEO, Paige

Stephanie Philbin - Partner, Goodwin Procter

(Moderator) Nick Tatonetti - Associate Professor, Columbia University

Date:  Tuesday, December 10, 2019
Time: 6:00 pm - 8:30 pm  (the discussion will take place approximately 6:30 - 8:00 pm with time for networking before and after.)
Location:  Goodwin Procter, 620 Eighth Ave. (bet. 40-41st Sts.), NYC
Tickets:  $35 for CBSACNY members; $45 for CBSACNY non-members; $60 at the door

SPECIAL OFFER:  Columbia Business School Alumni Club of New York offers ONE FREE EVENT (including this one) for new members who sign up for the first time ($85 or more). Click here to join now and then contact us to receive your promotional code before you register for the event of your choice (sports events, holiday parties and mixers are excluded.)


Bobby Ghoshal, CTO, ResMed
Bobby Ghoshal has been chief technology officer (CTO) for ResMed since April 2018. He previously served as chief operating officer for Brightree, a ResMed-owned provider of cloud-based software-as-a-service for out-of-hospital care. Prior to that Bobby led the information technology function for the U.S., Canada, and Latin America commercial teams, driving adoption of digital platforms and data analytics across the enterprise. Bobby has more than 25 years’ experience in technology across multiple industries including finance, semiconductors, and healthcare. Bobby has helped build and lead high-performance teams in information technology, innovation, digital and business strategy, information security, advanced analytics, operations, and customer care.

Leo Grady, CEO, Paige
Dr. Grady is the CEO of Paige and has over 15 years of experience in creating advanced medical imaging and AI-based software. Prior to joining Paige, he worked at HeartFlow building and launching the first cardiovascular product to noninvasively compute in vivo coronary blood flow and at Siemens in the Corporate Research division. In these roles he created and led the development, regulatory clearance and launch of innovative software products to extract complex information from a wide variety of medical imaging modalities, with a particular focus on cardiovascular and oncology applications. He is internationally recognized for his work on advanced algorithms for medical imaging, image segmentation, graph theory, computer vision and machine learning. Dr. Grady is a Fellow of the American Institute of Medical and Biomedical Engineers who has published two books, over 100 peer-reviewed journal and conference papers and has over 300 issued or pending patents worldwide.

Stephanie Philbin, Partner, Goodwin Procter
Ms. Philbin, a partner in the firm’s FDA group and a member of its Life Sciences practice, concentrates on Food and Drug Administration laws. She advises clients on regulatory and compliance issues including those related to Medical Device Reporting, clinical trials, premarket submissions, the Quality System Regulation, recalls, product importing and exporting, and product promotion. Ms. Philbin assists clients in responding to agency investigations and in filing comments with FDA to respond to various regulatory initiatives. She reviews SEC filings of FDA-regulated companies and conducts due diligence of companies as part of mergers and acquisitions and initial public offerings. Ms. Philbin also assists in litigation. 

(Moderator) Nick Tatonetti, Associate Professor, Columbia University
Nicholas Tatonetti, PhD, a tenured associate professor in the Columbia Department of Biomedical Informatics (DBMI), is an expert on the appropriate use of advanced data science methods, including artificial intelligence and machine learning, to investigate medicine safety. He will speak on the promise and pitfalls and limitations of applying big datasets to medical therapies. The Tatonetti Lab's projects have led to multiple publications in major medical journals and new avenues of research into the use of emerging resources such as electronic health records and genomic databases to address predict drug safety and efficacy in individual patients and to identify hereditary familial relationships for screening purposes. 

Thanks to the Healthcare Committee of the CBS Alumni Club of NY, especially Deepak Mittal '10, Chairman, Feng (Johnson) Qian '18, Vice Chairman, and Wendy Diller, for coordinating the program.

We'd especially like to thank our generous host, Goodwin Procter.

Get in Touch

Membership Software Powered by YourMembership  ::  Legal